Silence Therapeutics (SLN)

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

O preço da ação Silence Therapeutics Plc American Depository Share (SLN) after-hours hoje é de $ 6,00, refletindo uma movimentação de +9,49% after-hours desde que o mercado fechou. A capitalização de mercado da empresa é de $ 283,40 mi, com um volume comercial diário de $ 411,50 mil ações. Para investidores monitorando tendências de preços, a ação Silence Therapeutics Plc American Depository Share tem variado entre $ 5,37 e $ 6,45 hoje. O preço de fechamento anterior foi $ 5,48.

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Silence Therapeutics ações na Kraken a partir de US$ 10.